429 related articles for article (PubMed ID: 25820692)
1. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features.
Prete M; Dammacco R; Fatone MC; Racanelli V
Clin Exp Med; 2016 May; 16(2):125-36. PubMed ID: 25820692
[TBL] [Abstract][Full Text] [Related]
2. Current therapeutic approaches to autoimmune chronic uveitis in children.
Simonini G; Cantarini L; Bresci C; Lorusso M; Galeazzi M; Cimaz R
Autoimmun Rev; 2010 Aug; 9(10):674-83. PubMed ID: 20553975
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic strategy for the treatment of non-infectious uveitis proposed by an expert panel].
Diwo E; Sève P; Trad S; Bielefeld P; Sène D; Abad S; Brézin A; Quartier P; Koné Paut I; Weber M; Chiquet C; Errera MH; Sellam J; Cacoub P; Kaplanski G; Kodjikian L; Bodaghi B; Saadoun D
Rev Med Interne; 2018 Sep; 39(9):687-698. PubMed ID: 29610003
[TBL] [Abstract][Full Text] [Related]
4. Juvenile idiopathic arthritis-associated uveitis.
Clarke SL; Sen ES; Ramanan AV
Pediatr Rheumatol Online J; 2016 Apr; 14(1):27. PubMed ID: 27121190
[TBL] [Abstract][Full Text] [Related]
5. Management of sight-threatening uveitis: new therapeutic options.
Becker MD; Smith JR; Max R; Fiehn C
Drugs; 2005; 65(4):497-519. PubMed ID: 15733012
[TBL] [Abstract][Full Text] [Related]
6. [Uveitic macular edema].
Fardeau C; Champion E; Massamba N; LeHoang P
J Fr Ophtalmol; 2015 Jan; 38(1):74-81. PubMed ID: 25547721
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center.
Prete M; Guerriero S; Dammacco R; Fatone MC; Vacca A; Dammacco F; Racanelli V
J Ophthalmic Inflamm Infect; 2014; 4():17. PubMed ID: 25097673
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic options in uveitis.
Lightman S
Eye (Lond); 1997; 11 ( Pt 2)():222-6. PubMed ID: 9349417
[TBL] [Abstract][Full Text] [Related]
9. [Intraocular inflammation and homeostasis of the eye].
Mochizuki M
Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
[TBL] [Abstract][Full Text] [Related]
10. Approaches to immunosuppression in Behçet's disease.
Comarmond C; Wechsler B; Cacoub P; Saadoun D
Immunotherapy; 2013 Jul; 5(7):743-54. PubMed ID: 23829625
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of Behçet's disease].
Comarmond C; Wechsler B; Cacoub P; Saadoun D
Rev Med Interne; 2014 Feb; 35(2):126-38. PubMed ID: 24438860
[TBL] [Abstract][Full Text] [Related]
12. Intraocular inflammation in autoimmune diseases.
Pras E; Neumann R; Zandman-Goddard G; Levy Y; Assia EI; Shoenfeld Y; Langevitz P
Semin Arthritis Rheum; 2004 Dec; 34(3):602-9. PubMed ID: 15609264
[TBL] [Abstract][Full Text] [Related]
13. The role of interleukins and their inhibitors in the development of autoimmune uveitis.
Kuryltsiv NB; Halei KM
Wiad Lek; 2019; 72(4):716-722. PubMed ID: 31055563
[TBL] [Abstract][Full Text] [Related]
14. Uveitis management: a multidisciplinary approach to assess systemic involvement and side effects of treatments.
Peretz A; Guillaume MP; Casper-Velu L
Acta Clin Belg; 2002; 57(3):142-7. PubMed ID: 12212355
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD
Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
[TBL] [Abstract][Full Text] [Related]
16. Road to remission: a comprehensive review of therapy in uveitis.
Siddique SS; Shah R; Suelves AM; Foster CS
Expert Opin Investig Drugs; 2011 Nov; 20(11):1497-515. PubMed ID: 21936708
[TBL] [Abstract][Full Text] [Related]
17. [Significance of autoimmunity in various forms of uveitis].
Zierhut M; Klein R; Berg P; Thiel HJ
Klin Monbl Augenheilkd; 1991 Mar; 198(3):165-73. PubMed ID: 1829128
[TBL] [Abstract][Full Text] [Related]
18. Management of Uveitis in Spondyloarthropathy: Current Trends.
Gupta N; Agarwal A
Perm J; 2018; 22():17-041. PubMed ID: 29272246
[TBL] [Abstract][Full Text] [Related]
19. Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis.
Gallego-Pinazo R; Dolz-Marco R; Martínez-Castillo S; Arévalo JF; Díaz-Llopis M
Inflamm Allergy Drug Targets; 2013 Feb; 12(1):38-45. PubMed ID: 23441991
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T Cell Therapy for Uveitis: A New Promising Challenge.
Foussat A; Gregoire S; Clerget-Chossat N; Terrada C; Asnagli H; Lemoine FM; Klatzmann D; LeHoang P; Forte M; Bodaghi B
J Ocul Pharmacol Ther; 2017 May; 33(4):278-284. PubMed ID: 28448237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
